Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9
DUBLIN, Ireland, Aug. 02, 2023 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical…
Month: August 2023
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9
DUBLIN, Ireland, Aug. 02, 2023 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical…
Faron to Participate in Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference
Management to present on Thursday, August 10 at 12:30-12:55 PM Eastern Time at the InterContinental…
Faron to Participate in Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference
Management to present on Thursday, August 10 at 12:30-12:55 PM Eastern Time at the InterContinental…
Enlivex Announces Peer-Reviewed Publication in Frontiers in Immunology of Clinical Data Details Resolution of Acute Respiratory Distress Syndrome (ARDS) from two Phase I/II Trials Evaluating Allocetra in Patients with COVID-19
Data published in Frontiers in Immunology show a robust safety profile and rapid resolution from…
Enlivex Announces Peer-Reviewed Publication in Frontiers in Immunology of Clinical Data Details Resolution of Acute Respiratory Distress Syndrome (ARDS) from two Phase I/II Trials Evaluating Allocetra in Patients with COVID-19
Data published in Frontiers in Immunology show a robust safety profile and rapid resolution from…
Biora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conference
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
Biora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conference
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
Kala Pharmaceuticals Announces Name Change to KALA BIO
ARLINGTON, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (Nasdaq:KALA), a clinical-stage biopharmaceutical…
Kala Pharmaceuticals Announces Name Change to KALA BIO
ARLINGTON, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (Nasdaq:KALA), a clinical-stage biopharmaceutical…
Jasper Therapeutics Strengthens Management Team with Key Appointments
Patricia Carlos Appointed Senior Vice President of Regulatory Affairs and Quality Annette Marcantonio Appointed Vice…
Jasper Therapeutics Strengthens Management Team with Key Appointments
Patricia Carlos Appointed Senior Vice President of Regulatory Affairs and Quality Annette Marcantonio Appointed Vice…
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
REDWOOD CITY, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
Recce Pharmaceuticals Receives Second Canadian Scientific Research and Experimental Development Rebate
SYDNEY, Australia, Aug. 02, 2023 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q)…
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
REDWOOD CITY, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
EXL recognized as a Major Player in IDC MarketScape for Artificial Intelligence Services 2023
NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) — EXL, a leading data analytics and digital…
EXL recognized as a Major Player in IDC MarketScape for Artificial Intelligence Services 2023
NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) — EXL, a leading data analytics and digital…
Saviynt Secures New Digital Growth Strategy with HawkSearch
WOBURN, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a prominent…
Saviynt Secures New Digital Growth Strategy with HawkSearch
WOBURN, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a prominent…
Food Shippers of America Honors nuVizz for Achievement in Cold Chain Delivery
– nuVizz improves asset utilization by 35% for cold chain customers with real-time visibility and…